Regulation of the Muscarinic M Receptor by Myocardin-Related Transcription Factors
Date
2021-09-03Journal
Frontiers in PhysiologyPublisher
Frontiers Media S.A.Type
Article
Metadata
Show full item recordAbstract
Myocardin-related transcription factors (MRTFs: myocardin/MYOCD, MRTF-A/MRTFA, and MRTF-B/MRTFB) are co-factors of serum response factor (SRF) that activate the smooth muscle cell (SMC) gene program and that play roles in cardiovascular development and mechanobiology. Gain and loss of function experiments have defined the SMC gene program under control of MRTFs, yet full understanding of their impact is lacking. In the present study, we tested the hypothesis that the muscarinic M3 receptor (CHRM3) is regulated by MRTFs together with SRF. Forced expression of MYOCD (8d) in human coronary artery (SMC) followed by RNA-sequencing showed increased levels of M2, M3, and M5 receptors (CHRM2: 2-fold, CHRM3: 16-fold, and CHRM5: 2-fold). The effect of MYOCD on M3 was confirmed by RT-qPCR using both coronary artery and urinary bladder SMCs, and correlation analyses using human transcriptomic datasets suggested that M3 may also be regulated by MRTF-B. Head-to-head comparisons of MYOCD, MRTF-A and MRTF-B, argued that while all MRTFs are effective, MRTF-B is the most powerful transactivator of CHRM3, causing a 600-fold increase at 120h. Accordingly, MRTF-B conferred responsiveness to the muscarinic agonist carbachol in Ca2+ imaging experiments. M3 was suppressed on treatment with the MRTF-SRF inhibitor CCG-1423 using SMCs transduced with either MRTF-A or MRTF-B and using intact mouse esophagus in culture (by 92±2%). Moreover, silencing of SRF with a short hairpin reduced CHRM3 (by >60%) in parallel with α-actin (ACTA2). Tamoxifen inducible knockout of Srf in smooth muscle reduced Srf (by 54±4%) and Chrm3 (by 41±6%) in the urinary bladder at 10days, but Srf was much less reduced or unchanged in aorta, ileum, colon, trachea, and esophagus. Longer induction (21d) further accentuated the reduction of Chrm3 in the bladder and ileum, but no change was seen in the aorta. Single cell RNA-sequencing revealed that Mrtfb dominates in ECs, while Myocd dominates in SMCs, raising the possibility that Chrm3 may be driven by Mrtfb-Srf in the endothelium and by Myocd-Srf in SMCs. These findings define a novel transcriptional control mechanism for muscarinic M3 receptors in human cells, and in mice, that could be targeted for therapy.Rights/Terms
Copyright © 2021 Liu, Rippe, Hansson, Kryvokhyzha, Fisher, Ekman and Swärd.Identifier to cite or link to this item
http://hdl.handle.net/10713/16693ae974a485f413a2113503eed53cd6c53
10.3389/fphys.2021.710968
Scopus Count
Collections
Related articles
- Cell Type Dependent Suppression of Inflammatory Mediators by Myocardin Related Transcription Factors.
- Authors: Liu L, Bankell E, Rippe C, Morén B, Stenkula KG, Nilsson BO, Swärd K
- Issue date: 2021
- NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells.
- Authors: Rippe C, Morén B, Liu L, Stenkula KG, Mustaniemi J, Wennström M, Swärd K
- Issue date: 2021 Mar 16
- Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators.
- Authors: Swärd K, Krawczyk KK, Morén B, Zhu B, Matic L, Holmberg J, Hedin U, Uvelius B, Stenkula K, Rippe C
- Issue date: 2019 Dec 1
- Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
- Authors: Hinson JS, Medlin MD, Lockman K, Taylor JM, Mack CP
- Issue date: 2007 Feb
- Myocardin-related transcription factor B is required for normal mouse vascular development and smooth muscle gene expression.
- Authors: Wei K, Che N, Chen F
- Issue date: 2007 Feb